The pattern of use of non-steroidal anti.-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

被引:117
作者
Fosbol, Emil Loldrup [1 ]
Gislason, Gunnar H. [1 ,2 ]
Jacobsen, Soren [4 ]
Abildstrom, Steen Z. [1 ]
Hansen, Morten Look [1 ]
Schramm, Tina Ken [1 ,2 ]
Folke, Fredrik [1 ]
Sorensen, Rikke [1 ]
Rasmussen, Jeppe N. [2 ]
Kober, Lars [3 ]
Madsen, Mette [2 ]
Torp-Pedersen, Christian [1 ]
机构
[1] Gentofte Univ Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark
[2] Natl Inst Publ Hlth, Copenhagen, Denmark
[3] Rigshosp, Copenhagen Univ Hosp, Ctr Heart, Copenhagen, Denmark
[4] Rigshosp, Copenhagen Univ Hosp, Dept Rheumatol, Copenhagen, Denmark
关键词
non-steroidal anti-inflammatory drugs (NSAIDs); nationwide; pattern of use; pharmacoepidemiology;
D O I
10.1002/pds.1592
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To describe the nationwide pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) in the Danish population. Methods All Danish citizens aged 10 or above I January 1997 were included in the study. The national prescription registry was used to identify all claimed prescriptions for NSAIDs by the cohort until 2005. By individual-level-linkage of nationwide registries, information was acquired concerning hospitalizations, comorbidity, concomitant pharmacotherapy and socioeconomic factors. Results The population consisted of 4 614 807 individuals, of which 2 663 706 (57.8%) claimed at least one prescription for NSAID from 1997 to 2005. lbuprofen and diclofenac were the most frequently used non-selective NSAIDs, whereas rofecoxib and celecoxib were the most frequently used selective cyclooxygenase-2 (COX-2) inhibitors. The usage was similar across all age groups. Female sex and increasing age was associated with increased use of NSAID. Factors predicting extensive NSAID use were: rheumatic disease (odds ratio (OR) = 1.79,95% confidence interval (Cl): 1.69-1.90), gout agents (allopurinol) (OR = 2.54, CI: 2.44-2.64) and other pain medication (OR = 3.27, CI: 3.23-3.3 1). NSAIDs were most often prescribed for use for one distinct treatment interval and for a short period (overall inter-quartile range [IQR]: 9-66 days). High doses were used in a relatively large proportion of the population (8.9% for etodolac to 19.5% for celecoxib) and 54 373 (2.0%) claimed prescriptions for more than one NSAID at the same time. Conclusion NSAIDs were commonly used in the Danish population. Since NSAIDs have been associated with increased cardiovascular risk, further research on the overall risk associated with these drugs on a national scale is needed. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:822 / 833
页数:12
相关论文
共 43 条
  • [1] Andersen TF, 1999, DAN MED BULL, V46, P263
  • [2] Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association
    Antman, Elliott M.
    Bennett, Joel S.
    Daugherty, Alan
    Furberg, Curt
    Roberts, Harold
    Taubert, Kathryn A.
    [J]. CIRCULATION, 2007, 115 (12) : 1634 - 1642
  • [3] Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile
    Arellano, Felix M.
    Yood, Marianne Ulcickas
    Wentworth, Charles E.
    Oliveria, Susan A.
    Rivero, Elena
    Verma, Anila
    Rothman, Kenneth J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (12) : 861 - 872
  • [4] AVOM J, 1998, JAMA-J AM MED ASSOC, V279, P1458
  • [5] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    Day, R
    Ferraz, MB
    Hawkey, CJ
    Hochberg, MC
    Kvien, TK
    Schnitzer, TJ
    Weaver, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
  • [6] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
    Bresalier, RS
    Sandler, RS
    Quan, H
    Bolognese, JA
    Oxenius, B
    Horgan, K
    Lines, C
    Riddell, R
    Morton, D
    Lanas, A
    Konstam, MA
    Baron, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) : 1092 - 1102
  • [7] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [8] Utilisation pattern of nonspecific nonsteroidal anti-inflammatory drugs and COX-2 inhibitors in a local health service unit in northeast Italy
    Chiroli, S
    Chinellato, A
    Didoni, G
    Mazzi, S
    Lucioni, C
    [J]. CLINICAL DRUG INVESTIGATION, 2003, 23 (11) : 751 - 760
  • [9] National trends in cyclooxygenase-2 inhibitor use since market release - Nonselective diffusion of a selectively cost-effective innovation
    Dai, CL
    Stafford, RS
    Alexander, C
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (02) : 171 - 177
  • [10] ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES
    DEYO, RA
    CHERKIN, DC
    CIOL, MA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) : 613 - 619